Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Marstacimab for People with Severe Hemophilia A or Moderate to Severe Hemophilia B Without Inhibitors: A Plain Language Summary of Publication of the BASIS Study.
Journal: Therapeutic advances in hematology
Published: January 28, 2026
Marstacimab prophylaxis in hemophilia A/B without inhibitors: results from the phase 3 BASIS trial.
Journal: Blood
Published: November 19, 2024
Safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of marstacimab in Chinese participants with severe haemophilia.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: February 22, 2023
Long-term safety and efficacy of the anti-tissue factor pathway inhibitor marstacimab in participants with severe haemophilia: Phase II study results.
Journal: British journal of haematology
Published: January 07, 2022
COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members.
Journal: International journal of chronic obstructive pulmonary disease
Published: February 03, 2016
Showing 1-6 of 6
Last Updated: 09/26/2026